Cargando…
Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
BACKGROUND: Peroxisome proliferator-activated receptors (PPARs) have emerged as important drug targets for diabetes. Drugs that activate PPARγ, such as the thiazolidinediones (TZDs), are widely used for treatment of Type 2 diabetes mellitus. PPARγ signaling could also play an anti-neoplastic role in...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1934377/ https://www.ncbi.nlm.nih.gov/pubmed/17584937 http://dx.doi.org/10.1186/1741-7015-5-17 |